摘要
目的调查高原地区高血压患者治疗率、控制率及降压治疗方案。方法回顾性分析西藏自治区人民政府驻成都办事处医院2013年10月—12月住院藏族高血压患者的病历资料。结果共纳入患者165例,接受降压治疗143例(86.7%),降压治疗后达标34例(23.8%),接受降压治疗的患者依从率为43.4%。降压方案中,单药治疗116例(81.1%),其中藏药、钙通道阻滞剂、利尿剂及传统复方制剂的治疗比例分别是24.1%、21.6%、19.0%、18.1%。结论高血压的治疗率高,但降压治疗的依从性和控制率低。需加强对高原地区基层医生的专业知识培训,同时加强高血压患者的健康教育。
Objective To explore the effect of antihypertensive therapy for hypertension patients from plateau area. Method A retrospective analysis of medical records for Tibetan patients with hypertension from October to December 2013 in Hospital of Chengdu Office of People's Government of Tibetan Autonomous Region. Results The study recruited 165 patients. The rate of treatment, control, and compliance of hypertension patients were 86.7% (143/165), 23.8% (34/143), 43.4% (62/143), respectively. The main characteristics of hypertension treatment were higher proportions of single-drug therapy (81.1%, 116/143); among those the Tibetan drug (24.1%), calcium channel blockers (21.6%), diuretics (19.0%), and traditional compound preparation (18.1%) were most commonly used in the antihypertensive therapy. Conclusions The rate of treatment was high, but the rate of control and compliance were low in Tibetan patients with hypertension. It was necessary to carry out hypertension education to patients and strengthen the training of doctors at the plateau.
作者
赵丽明
李晓萍
周瑶
李洪卫
贺斌
刘兰昕
杜薇
吴勇
马敏
黄方洋
付永兴
祝烨
ZHAO Liming1, LlXiaoping1, ZHOU Yao1, LI Hongwei1, HE Bin1, LIU Lanxin1, DU Wei1, WU Yong1, MA Min2, HUANG Fangyang2, FU Yongxing2, ZHU Ye2(1. Department of Cardiovascular Medicine, Hospital of Chengdu Office of People's Government of Tibetan Autonomous Region, Chengdu, Sichuan 610041, P. R. China 2. Department of Cardiology, West China Hospital, Sichuan University, Chenvdu,Sichuan 610041, P. R. Chin)
出处
《华西医学》
CAS
2018年第3期317-320,共4页
West China Medical Journal
关键词
高原
高血压
降压药物
Plateau
Hypertension
Antihypertensive